Key result
Persistent AF and higher LAVI link to distinct atrial 18F-FDG and 18F-FAPI uptake patterns.
Why the study?
Atrial remodeling in AF involves metabolic alterations and fibroblast activation, but the spatial patterns of these processes assessed by 18F-FDG and 18F-FAPI PET are not well characterized or compared.
Does 18F-FAPI PET demonstrate a different spatial pattern of atrial remodeling compared to 18F-FDG PET in patients with atrial fibrillation?
Cross-Sectional (n=152)
No
Does 18F-FAPI PET demonstrate a different spatial pattern of atrial remodeling compared to 18F-FDG PET in patients with atrial fibrillation?
18F-FDG and 18F-FAPI PET demonstrate spatially divergent uptake patterns in the atria of patients with atrial fibrillation, suggesting they provide complementary non-invasive information on inflammatory versus fibrotic atrial remodeling.
Answers are grounded in this paper and cite their sources.
Dual-tracer PET may distinguish metabolic from fibrotic atrial remodeling in AF; leaves open clinical adoption without prospective validation.
Atrial remodeling in atrial fibrillation (AF) involves multiple biological processes, including metabolic alterations, inflammation-related metabolic activity, and fibroblast activation, which can be assessed non-invasively with 18 F-fluorodeoxyglucose (FDG) and fibroblast activation protein inhibitors (FAPI) PET, respectively. We aimed to characterize and compare the atrial uptake patterns of these two tracers in patients with AF. In this post hoc cardinality-matched analysis of two prospective PET/CT cohorts, 90 patients with AF were included (45 imaged with ¹⁸F-FDG and 45 with ¹⁸F-FAPI). Left atrial volume index (LAVI) was measured using the echocardiographic ellipsoid method. The prevalence, intensity, and spatial distribution of atrial tracer uptake were compared between tracers, and clinical correlates of abnormal uptake were assessed using univariable analyses and logistic regression. ¹⁸F-FAPI showed a higher left atrial (LA) target-to-background ratio than ¹⁸F-FDG ( P = 0.007). Abnormal uptake was more frequent with ¹⁸F-FDG in the left atrial appendage (LAA; 83.3% vs. 23.1%, P < 0.001), and more frequent with ¹⁸F-FAPI in the LA anterior wall (84.6% vs. 38.9%, P = 0.002) and LA roof (69.2% vs. 33.3%, P = 0.019). These differences persisted in persistent AF (PsAF); in paroxysmal AF, only the higher LAA ¹⁸F-FDG uptake remained ( P = 0.015). Abnormal right atrial ¹⁸F-FDG uptake was associated with PsAF ( P = 0.010), whereas abnormal LA ¹⁸F-FAPI uptake was associated with higher LAVI ( P = 0.021) and lower low-density lipoprotein cholesterol ( P = 0.006). ¹⁸F-FDG and ¹⁸F-FAPI PET demonstrated spatially divergent atrial uptake patterns in AF, suggesting cohort-level complementary information on metabolically active atrial remodeling and activated fibroblast-associated remodeling. This complementarity requires within-patient validation. Spatially divergent ¹⁸F-FDG and ¹⁸F-FAPI uptake patterns across left atrial regions in patients with AF. Representative PET/CT images and bar plots show cohort-level regional differences in abnormal tracer uptake in predefined LA regions. FDG, fluorodeoxyglucose; FAPI, fibroblast activation protein inhibitor; AF, atrial fibrillation; LA, left atrium; LAA, left atrial appendage; AS, atrial septum; LA-AW, left atrial anterior wall; LA-PW, left atrial posterior wall
No takes yet. Share an insight, caveat, or question.
Duan et al. (2026) conducted a cross-sectional in Atrial fibrillation (n=152). 18F-FDG and 18F-FAPI PET imaging vs. Patients without abnormal tracer uptake was evaluated. In patients with atrial fibrillation, persistent AF was associated with abnormal right atrial 18F-FDG uptake, while increased left atrial volume index was associated with abnormal left atrial 18F-FAPI uptake.
Synapse has enriched 10 related papers. Consider them for comparative context: